🇺🇸 FDA
Patent

US 9175049

Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection

granted A61KA61K2039/552A61K2039/6068

Quick answer

US patent 9175049 (Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K2039/552, A61K2039/6068, A61K39/04, A61P